Vitamin E Improves Liver Health in Patients With MASLD - EMJ

Vitamin E Improves Liver Health in Patients with MASLD

1 Mins
Hepatology

A NEW study has found that vitamin E supplementation can significantly improve liver health in adults with metabolic dysfunction-associated steatotic liver disease (MASLD). 

The study aimed to provide a comprehensive analysis of vitamin E’s effectiveness in reducing liver inflammation and improving liver histology in patients with this condition. 

Researchers conducted a systematic review of randomised controlled trials, analysing data from seven studies that met the criteria for inclusion in the meta-analysis. The results showed that vitamin E significantly reduced levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), two key markers of liver inflammation. The standardisation mean differences were -0.82 (95% confidence interval [CI]: -1.13−-0.51) and -0.68 (95% CI: -0.94−-0.41), respectively. 

In addition to lowering inflammation markers, vitamin E also had a positive impact on liver histology. The meta-analysis revealed that vitamin E significantly reduced steatosis, lobular inflammation, and hepatocyte ballooning, which are key indicators of liver damage. Moreover, patients receiving vitamin E were nearly twice as likely to experience resolution of metabolic dysfunction-associated steatohepatitis. 

However, the study found that vitamin E did not significantly reduce fibrosis, a key marker of advanced liver damage, with a mean difference of -0.23 (95% CI: -0.51−0.05). Despite this, the overall findings suggest that vitamin E has notable benefits in reducing liver inflammation and improving liver histology in MASLD patients. 

In conclusion, the findings of this study support the use of vitamin E as an effective treatment option for reducing liver inflammation and improving histology in patients with MASLD. While vitamin E may not significantly impact fibrosis, it has benefits in other aspects of liver health that make it a promising option for managing this liver condition. However, further research is needed to explore it’s long-term effects and potential integration into broader treatment protocols. 

Aleksandra Zurowska, EMJ 

Reference 

Chee NMZ et al. Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis. JGH. 2024; doi.org/10.1111/jgh.16723. 

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?